Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Anglesio

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Gynecologic Oncology|August 5, 2022
Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancerAmanika Kumar, Chen Wang, Shannon P Sheedy, et al.
American Journal of Cancer Research|November 9, 2016
Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell linesMarta Llauradó Fernández, Gabriel E DiMattia, Amy Dawson, et al.
Human Reproduction (Oxford, England)|December 19, 2024
Somatic PTEN and ARID1A loss and endometriosis disease burden: a longitudinal studyDwayne R Tucker, Anna F Lee, Natasha L Orr, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 5, 2025
Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entityAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
Plos One|October 12, 2013
Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer ResearchMichael S Anglesio, Kimberly C Wiegand, Nataliya Melnyk, et al.
Plos One|September 12, 2013
Type-specific cell line models for type-specific ovarian cancer researchMichael S Anglesio, Kimberly C Wiegand, Nataliya Melnyk, et al.
The Journal of Pathology|June 13, 2019
Oncogenic mutations in histologically normal endometrium: the new normal?Vivian Lac, Tayyebeh M Nazeran, Basile Tessier-Cloutier, et al.
The Journal of Pathology|June 3, 2015
Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesisJiamin Chen, Yemin Wang, Melissa K McMonechy, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
M2 Macrophages are Major Mediators of Germline Risk of Endometriosis and Explain Pleiotropy with Comorbid TraitsSoledad Ochoa, Fernanda S Rasquel-Oliveira, Brett McKinnon, et al.
Plos One|September 17, 2010
Copy number analysis identifies novel interactions between genomic loci in ovarian cancerKylie L Gorringe, Joshy George, Michael S Anglesio, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Gynecologic Oncology|August 5, 2022
Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancerAmanika Kumar, Chen Wang, Shannon P Sheedy, et al.
American Journal of Cancer Research|November 9, 2016
Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell linesMarta Llauradó Fernández, Gabriel E DiMattia, Amy Dawson, et al.
Human Reproduction (Oxford, England)|December 19, 2024
Somatic PTEN and ARID1A loss and endometriosis disease burden: a longitudinal studyDwayne R Tucker, Anna F Lee, Natasha L Orr, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 5, 2025
Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entityAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
Plos One|October 12, 2013
Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer ResearchMichael S Anglesio, Kimberly C Wiegand, Nataliya Melnyk, et al.
Plos One|September 12, 2013
Type-specific cell line models for type-specific ovarian cancer researchMichael S Anglesio, Kimberly C Wiegand, Nataliya Melnyk, et al.
The Journal of Pathology|June 13, 2019
Oncogenic mutations in histologically normal endometrium: the new normal?Vivian Lac, Tayyebeh M Nazeran, Basile Tessier-Cloutier, et al.
The Journal of Pathology|June 3, 2015
Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesisJiamin Chen, Yemin Wang, Melissa K McMonechy, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
M2 Macrophages are Major Mediators of Germline Risk of Endometriosis and Explain Pleiotropy with Comorbid TraitsSoledad Ochoa, Fernanda S Rasquel-Oliveira, Brett McKinnon, et al.
Plos One|September 17, 2010
Copy number analysis identifies novel interactions between genomic loci in ovarian cancerKylie L Gorringe, Joshy George, Michael S Anglesio, et al.
Pageof 9